CSI Market
Sign In | Register

Avadel Pharmaceuticals Plc (AVDL) Annual Balance Sheets

Annual · GAAP · USD millions
Access AVDL quarterly Balance Sheets →
The table below presents a historical view of Avadel Pharmaceuticals Plc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent51.37
Marketable Securities, Current SH0.16
Other Short-term Investments0.00
Cash & Short-term Investments51.00
Accounts receivable34.10
Notes Receivable, Current0.00
Inventories10.14
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.04
Total Current Assets134.21
Equipment/Property/Plant Net0.45
Goodwill net16.84
Intangible Assets0.00
Long-term investments0.00
Deferred Tax Assets, Net, Noncurrent AS101.57
Other Assets, Noncurrent12.74
Research And Development Tax Credit Receivable Current-
Research And Development Tax Credit Receivable Non Current-
Total Assets164.24
Liabilities
Accounts Payable, Current AC7.33
Accrued Liabilities, Current AC40.65
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.27
Taxes Payable, Current, Total2.72
Total Current Liabilities48.83
Long-term debt0.00
Capital Lease and Other0.00
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent41.55
Operating Lease Liability Current0.58
Operating Lease Liability Noncurrent1.12
Total Liabilities90.39
Stockholders' Equity
Common Stock Value0.97
Treasury Stock Value0.00
Additional Paid In Capital Common Stock891.79
Retained Earnings / Accumulated Deficit-794.33
Accumulated Other Comprehensive Income-24.58
Other Equity-24.58
Common Stockholder's Equity73.85
Preferred Stockholder's Equity0.00
Total Stockholder's Equity73.85
Liabilities & Stockholder's Equity164.24
4 historic quarters locked

Sign in to unlock the full Avadel Pharmaceuticals Plc balance sheet history.

Sign In Create Free Account

About Avadel Pharmaceuticals Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001012477-25-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License